Uniciproxacin Inj.
- Active Ingredients
- Ciprofloxacin 2mg/mL
- Indications
- 1. Effective species
E. coli, shigella, salmonella, citrobacter, klebsiella, enterobacter, ceratia, proteus (indole positive and negative), pseudomonas, neisseria, acinetobacter, streptococcus, chlamydia, staphylococcus, bacteroid
2. Indications
1) Respiratory infections
2) Ear-nose-throat infections
3) Kidney and urinary tract infections
4) Genital infections including gonorrhea
5) Gastrointestinal tract infections
6) Infectious diseases of the bile ducts
7) Infections and wounds on skin and soft tissues
8) Infectious diseases of bones and joints
9) Obstetric infections
10) Sepsis, peritonitis
Fluoroquinolone-based drugs, including this drug, are associated with serious adverse reactions, so acute bacterial sinusitis, acute bacterial exacerbation of chronic bronchitis, and simple urinary tract infections are used in patients without other treatments
(Injective)
1.Dose
1) Normally 100 to 400 mg once daily, twice daily as ciprofloxacin.
2. Duration of administration: Usually, the average duration of administration of Rosacea is 7 to 14 days. For bone or joint infections, the duration of administration should be 4 to 6 weeks or longer. Even after the symptoms of infection disappear, an additional two days should be given.
This drug is administered intravenously over 60 minutes and the dose should be determined in consideration of the degree of infection of each patient, the susceptibility of the causative organism, the patient's condition, and liver and kidney function. After the initial intravenous treatment, the patient may be switched to oral medication depending on the condition of the patient.